I Petri

408 total citations
24 papers, 312 citations indexed

About

I Petri is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, I Petri has authored 24 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Organic Chemistry. Recurrent topics in I Petri's work include Synthesis and Biological Evaluation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). I Petri is often cited by papers focused on Synthesis and Biological Evaluation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). I Petri collaborates with scholars based in Hungary, Nigeria and Czechia. I Petri's co-authors include Joséph Molnár, Ákos Mesterházy, Örs Péter Horváth, András Petri, Yukihiro Shoyama, József Molnár, Yvette Mándi, Diána Szabó, P. Szenohradszky and Tibor Kalmár and has published in prestigious journals such as The Lancet, American Journal of Kidney Diseases and Toxicology in Vitro.

In The Last Decade

I Petri

23 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Petri Hungary 8 160 68 52 43 42 24 312
Mary Witt United States 9 320 2.0× 118 1.7× 26 0.5× 43 1.0× 19 0.5× 14 525
I Dvorăcková Czechia 10 239 1.5× 76 1.1× 28 0.5× 13 0.3× 22 0.5× 23 354
Arto Lahti Finland 16 82 0.5× 47 0.7× 16 0.3× 63 1.5× 9 0.2× 31 932
Flemming Lund Denmark 12 109 0.7× 60 0.9× 79 1.5× 13 0.3× 23 0.5× 31 391
Hiroki Okumura Japan 9 135 0.8× 111 1.6× 20 0.4× 54 1.3× 12 0.3× 29 357
Yonglie Chu China 13 97 0.6× 231 3.4× 35 0.7× 43 1.0× 20 0.5× 35 519
Vladimir Nešić Serbia 8 132 0.8× 77 1.1× 66 1.3× 18 0.4× 22 0.5× 33 416
Deborah Cooper Australia 9 29 0.2× 112 1.6× 65 1.3× 39 0.9× 40 1.0× 12 352
A. P. Jayaraj United Kingdom 14 74 0.5× 79 1.2× 192 3.7× 14 0.3× 61 1.5× 46 458
Taotao Huang China 9 103 0.6× 94 1.4× 17 0.3× 23 0.5× 21 0.5× 21 320

Countries citing papers authored by I Petri

Since Specialization
Citations

This map shows the geographic impact of I Petri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Petri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Petri more than expected).

Fields of papers citing papers by I Petri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Petri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Petri. The network helps show where I Petri may publish in the future.

Co-authorship network of co-authors of I Petri

This figure shows the co-authorship network connecting the top 25 collaborators of I Petri. A scholar is included among the top collaborators of I Petri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Petri. I Petri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varga, Éva, et al.. (2003). The role of HLA-DRB1 04 alleles and their association with HLA-DQB genes in genetic susceptibility to rheumatoid arthritis in Hungarian patients. Acta Microbiologica et Immunologica Hungarica. 50(1). 33–41. 7 indexed citations
2.
Petri, I, et al.. (2002). The immunosuppressive effect of Fusarium mycotoxin as a function of HLA antigens. Acta Microbiologica et Immunologica Hungarica. 49(1). 99–104. 1 indexed citations
3.
Petri, I, et al.. (2001). Effects of mycotoxins on human immune functions in vitro. Toxicology in Vitro. 15(1). 25–30. 158 indexed citations
4.
Szabó, Diána, et al.. (2001). Effects of naturally occurring glucosides, solasodine glucosides, ginsenosides and parishin derivatives on multidrug resistance of lymphoma cells and leukocyte functions.. PubMed. 15(2). 151–6. 20 indexed citations
5.
Andrikovics, Hajnalka, Izabella Klein, Lajos Kalmár, et al.. (1999). [A new method of molecular testing in the differential diagnosis of hereditary hemochromatosis].. PubMed. 140(45). 2517–22. 4 indexed citations
6.
Iványi, Béla, E. Endreffy, P. Szenohradszky, et al.. (1998). Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: An 11-year follow-up. American Journal of Kidney Diseases. 32(6). 1068–1074. 15 indexed citations
7.
Barbé, Jordi, Yvette Mándi, Aviv Hever, et al.. (1996). Effects of acridines on bacterial plasmid replication and endotoxin.. PubMed. 10(6). 601–6. 6 indexed citations
8.
Petri, I, et al.. (1996). Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.. PubMed. 16(3A). 1247–50. 4 indexed citations
9.
Petri, I, et al.. (1995). Immunomodulating effect of acridine tautomers on eukaryotic cells.. PubMed. 42(2). 203–8. 2 indexed citations
10.
Molnár, Joséph, Yvette Mándi, I Petri, et al.. (1993). Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.. PubMed. 13(2). 439–42. 11 indexed citations
11.
Monostori, Éva, et al.. (1990). Efficient cell mediated lysis of human erythrocyte target cells is mediated by a human glycophorine A specific murine monoclonal antibody.. PubMed. 23(4). 229–32. 2 indexed citations
12.
Molnár, J, Ilona Mucsi, M. Koltai, et al.. (1989). Antimicrobial and immunomodulating effects of some phenolic glycosides.. PubMed. 36(4). 425–32. 13 indexed citations
13.
László, A, I Petri, & K. Gyurkovits. (1987). Spontaneous and stimulated lymphocyte transformation test in homozygous children with cystic fibrosis.. PubMed. 28(2). 101–5. 1 indexed citations
14.
Petri, I, et al.. (1986). Antibody dependent cellular cytotoxicity (ADCC)-reaction and an in vitro steroid sensitivity test of peripheral lymphocytes in children with malignant haematological and autoimmune diseases.. PubMed. 27(1). 23–9. 6 indexed citations
15.
Horváth, Örs Péter, et al.. (1985). Late malignant transformation of chronic corrosive oesophageal strictures. Langenbeck s Archives of Surgery. 365(4). 231–238. 38 indexed citations
16.
Horváth, Örs Péter, et al.. (1982). [Possible etiologic factors in the development of esophageal cancer].. PubMed. 123(16). 971–6. 1 indexed citations
17.
Petri, I, et al.. (1981). Cellular immune functions after heart operations.. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 22(1-2). 29–36. 3 indexed citations
18.
Petri, I, et al.. (1981). [Premalignant and malignant changes in the epithelium in an antethoracic skin tube after esophagus replacement surgery].. PubMed. 52(8). 501–4. 6 indexed citations
19.
Petri, I, et al.. (1974). [Studying the immune reactivity of uremic patients by phytohemagglutinin-stimulated lymphocyte culture].. PubMed. 115(11). 613–5. 1 indexed citations
20.
Petri, I. (1973). PERSISTENCE OF Au-SH ANTIGEN AND LYMPHOCYTE TRANSFORMATION. The Lancet. 302(7832). 802–803. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026